Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei
- PMID: 25814953
- PMCID: PMC4356943
- DOI: 10.3389/fphar.2015.00032
Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei
Abstract
Drug resistance in pathogenic protozoa is very often caused by changes to the 'transportome' of the parasites. In Trypanosoma brucei, several transporters have been implicated in uptake of the main classes of drugs, diamidines and melaminophenyl arsenicals. The resistance mechanism had been thought to be due to loss of a transporter known to carry both types of agents: the aminopurine transporter P2, encoded by the gene TbAT1. However, although loss of P2 activity is well-documented as the cause of resistance to the veterinary diamidine diminazene aceturate (DA; Berenil(®)), cross-resistance between the human-use arsenical melarsoprol and the diamidine pentamidine (melarsoprol/pentamidine cross resistance, MPXR) is the result of loss of a separate high affinity pentamidine transporter (HAPT1). A genome-wide RNAi library screen for resistance to pentamidine, published in 2012, gave the key to the genetic identity of HAPT1 by linking the phenomenon to a locus that contains the closely related T. brucei aquaglyceroporin genes TbAQP2 and TbAQP3. Further analysis determined that knockdown of only one pore, TbAQP2, produced the MPXR phenotype. TbAQP2 is an unconventional aquaglyceroporin with unique residues in the "selectivity region" of the pore, and it was found that in several MPXR lab strains the WT gene was either absent or replaced by a chimeric protein, recombined with parts of TbAQP3. Importantly, wild-type AQP2 was also absent in field isolates of T. b. gambiense, correlating with the outcome of melarsoprol treatment. Expression of a wild-type copy of TbAQP2 in even the most resistant strain completely reversed MPXR and re-introduced HAPT1 function and transport kinetics. Expression of TbAQP2 in Leishmania mexicana introduced a pentamidine transport activity indistinguishable from HAPT1. Although TbAQP2 has been shown to function as a classical aquaglyceroporin it is now clear that it is also a high affinity drug transporter, HAPT1. We discuss here a possible structural rationale for this remarkable ability.
Keywords: HAPT1; Trypanosoma brucei; aquaglyceroporin; aquaporin; drug resistance; drug transport; melarsoprol; pentamidine.
Figures
Similar articles
-
Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs.J Antimicrob Chemother. 2014 Mar;69(3):651-63. doi: 10.1093/jac/dkt442. Epub 2013 Nov 13. J Antimicrob Chemother. 2014. PMID: 24235095 Free PMC article.
-
Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol.PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2475. doi: 10.1371/journal.pntd.0002475. eCollection 2013. PLoS Negl Trop Dis. 2013. PMID: 24130910 Free PMC article.
-
Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter Trypanosoma brucei.Elife. 2020 Aug 11;9:e56416. doi: 10.7554/eLife.56416. Elife. 2020. PMID: 32762841 Free PMC article.
-
An Update on African Trypanocide Pharmaceutics and Resistance.Front Vet Sci. 2022 Mar 7;9:828111. doi: 10.3389/fvets.2022.828111. eCollection 2022. Front Vet Sci. 2022. PMID: 35356785 Free PMC article. Review.
-
Melarsoprol Resistance in African Trypanosomiasis.Trends Parasitol. 2018 Jun;34(6):481-492. doi: 10.1016/j.pt.2018.04.002. Epub 2018 Apr 25. Trends Parasitol. 2018. PMID: 29705579 Review.
Cited by
-
Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies.Int J Parasitol Drugs Drug Resist. 2024 Aug;25:100533. doi: 10.1016/j.ijpddr.2024.100533. Epub 2024 Mar 30. Int J Parasitol Drugs Drug Resist. 2024. PMID: 38555795 Free PMC article. Review.
-
An In vitro and in silico investigation of the antitrypanosomal activities of the stem bark extracts of Anopyxis klaineana (Pierre) Engl.Heliyon. 2024 Mar 16;10(6):e28025. doi: 10.1016/j.heliyon.2024.e28025. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38545221 Free PMC article.
-
Synthesis and Biophysical and Biological Studies of N-Phenylbenzamide Derivatives Targeting Kinetoplastid Parasites.J Med Chem. 2023 Oct 12;66(19):13452-13480. doi: 10.1021/acs.jmedchem.3c00697. Epub 2023 Sep 20. J Med Chem. 2023. PMID: 37729094 Free PMC article.
-
Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies.Int J Mol Sci. 2023 Aug 7;24(15):12529. doi: 10.3390/ijms241512529. Int J Mol Sci. 2023. PMID: 37569903 Free PMC article. Review.
-
Targeting Metalloenzymes: The "Achilles' Heel" of Viruses and Parasites.Pharmaceuticals (Basel). 2023 Jun 19;16(6):901. doi: 10.3390/ph16060901. Pharmaceuticals (Basel). 2023. PMID: 37375848 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous